This study evaluates an investigational medication in patients with gastroentero-pancreatic neuroendocrine tumor (GEP-NET). The purpose of this study is to evaluate the investigational medication compared to Octreotide Microspheres in patients with advanced GEP-NET.
The study will focus on assessing the safety and effectiveness of the investigational medication. It will also look at how the medication is processed in the body, known as pharmacokinetics.
- Who can participate: Adults aged 18 and older with advanced gastroentero-pancreatic neuroendocrine tumor may be eligible. Participants should have at least one measurable lesion and a history of limited prior treatments.
- Study details: Participants will receive either the investigational medication or Octreotide Microspheres. The study will compare their effects.
How understandable was the trial content above?
Hard to understand
Easy to understand